Searched for
FDA NOD FOR ZAYNICH
Zydus Therapeutics' saroglitazar drug granted priority review by US FDAZydus Therapeutics' drug saroglitazar has received priority review from the US FDA. This drug treats primary biliary cholangitis, a liver d...- Wockhardt shares jump over 4%, extend two-day rally following FDA nod for ZaynichWockhardt Ltd shares jumped over 4% to ₹1,533, extending a two-day rally after surging nearly 20% on Tuesday. The rise follows the US FDA’s...
- Load More